Proto Labs (NYSE:PRLB) Announces Earnings Results

Posted by on Jul 31st, 2026

Proto Labs (NYSE:PRLB – Get Free Report) issued its earnings results on Friday. The industrial products company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.54 by $0.06, FiscalAI reports. The company had revenue of $149.34 million during the quarter, compared to analysts’ expectations of $144.53 million. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The business’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.41 EPS. Proto Labs updated its Q3 2026 guidance to 0.560-0.640 EPS.

Here are the key takeaways from Proto Labs’ conference call:

  • Record results and raised outlook: Q2 revenue reached a record $149.3 million, up 10.2% year over year in constant currency, while adjusted EPS rose 45% to $0.60. Management raised its full-year 2026 revenue-growth forecast to 8%–10%.
  • Factory services drove momentum: CNC Machining revenue grew 13.1% and Injection Molding increased 12.9%, with particular strength in aerospace and defense, telecommunications, medical devices, and larger customer orders. Adjusted operating margin improved 340 basis points, supported by gross-margin expansion and operating leverage.
  • Increasing production opportunity: Proto Labs said larger strategic customers are expanding relationships beyond prototyping into production, supported by certifications, quality systems, and capabilities such as traceability and process validation. The company is also evaluating acquisitions to add production capabilities in its existing service areas.
  • Europe remains a profitability headwind: European revenue grew 7.3% in constant currency, but management cautioned that the region’s profitability recovery is still a medium-term work in progress despite go-to-market changes and a newly simplified commercial structure. 3D Printing revenue also declined 2.7%, primarily because of a 6.7% drop in Europe.

Proto Labs Trading Down 0.8%

Shares of PRLB stock traded down $0.63 on Friday, hitting $74.51. The stock had a trading volume of 286,606 shares, compared to its average volume of 195,156. Proto Labs has a twelve month low of $40.84 and a twelve month high of $83.15. The company has a fifty day moving average price of $76.94 and a two-hundred day moving average price of $66.64. The firm has a market cap of $1.77 billion, a P/E ratio of 70.29 and a beta of 1.38.

Insider Buying and Selling at Proto Labs

In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of Proto Labs stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total transaction of $154,560.00. Following the transaction, the director directly owned 32,505 shares in the company, valued at approximately $2,511,986.40. The trade was a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Michael R. Kenison sold 16,030 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $69.49, for a total value of $1,113,924.70. Following the completion of the transaction, the insider directly owned 18,683 shares of the company’s stock, valued at approximately $1,298,281.67. The trade was a 46.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 25,663 shares of company stock worth $1,804,727 in the last ninety days. 1.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Creative Planning boosted its stake in Proto Labs by 9.0% in the 3rd quarter. Creative Planning now owns 6,883 shares of the industrial products company’s stock worth $344,000 after purchasing an additional 569 shares during the period. Zacks Investment Management acquired a new position in shares of Proto Labs during the 4th quarter worth approximately $325,000. Ieq Capital LLC bought a new stake in Proto Labs during the fourth quarter worth $311,000. Mercer Global Advisors Inc. ADV acquired a new stake in Proto Labs in the 3rd quarter valued at about $291,000. Finally, Prelude Capital Management LLC acquired a new stake in Proto Labs during the 3rd quarter valued at $264,000. Institutional investors own 84.54% of the company’s stock.

Proto Labs News Roundup

Here are the key news stories impacting Proto Labs this week:

  • Positive Sentiment: Q2 results exceeded expectations. Proto Labs reported earnings of $0.60 per share, ahead of the $0.54 consensus estimate and up from $0.41 a year earlier. Revenue reached a record $149.3 million, exceeding expectations of $144.5 million and increasing approximately 10.5% year over year. Proto Labs Q2 Earnings and Revenues Top Estimates
  • Positive Sentiment: Operating momentum remained healthy. Total revenue per customer contact rose 16.7% year over year, while CNC machining revenue increased 13.6%, supporting the company’s growth profile. Protolabs Reports Financial Results for the Second Quarter of 2026
  • Positive Sentiment: Q3 EPS guidance was notably above expectations. Management forecast earnings of $0.56 to $0.64 per share, compared with the $0.48 analyst consensus, implying continued earnings strength.
  • Neutral Sentiment: Revenue guidance was broadly in line. The Q3 revenue outlook of $145 million to $153 million has a midpoint slightly above the $145.9 million consensus, but does not signal a major upside surprise on sales.
  • Negative Sentiment: Valuation may be limiting the reaction. Proto Labs trades at roughly 70 times earnings, leaving the stock vulnerable to profit-taking when forward revenue growth is moderate, even after the quarterly beat. The company’s net margin was 4.71%, which also underscores the importance of sustained margin improvement.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on PRLB. Benchmark lifted their price objective on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Weiss Ratings upgraded Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, July 17th. Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 18th. Finally, Zacks Research cut Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 3rd. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $65.33.

Check Out Our Latest Research Report on PRLB

Proto Labs Company Profile

(Get Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

Featured Stories

Earnings History for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.